AQST vs NWSA · rev $28.3M vs rev $9.03B
Aquestive Therapeutics Inc (AQST) versus NWSA (NWSA) — a side-by-side from cached financials, not a winner call.
Aquestive Therapeutics Inc (AQST) is a drug manufacturers - specialty & generic company listed on US.
NWSA (NWSA) common stock.
Latest reported AQST revenue for 2026-06-30 was $28.3M. Net income was -$30.9M. Revenue was up 95.7% from 2026-03-31 to 2026-06-30. AQST currently screens at market cap $493.0M.
Latest reported NWSA revenue for 2026-06-30 was $9.03B. Net income was $573.0M. Revenue was up 328.1% from 2025-06-30 to 2026-06-30. NWSA currently screens at market cap $0.
AQST currently screens at market cap $493.0M. NWSA currently screens at market cap $0.
Not investment advice. Open the AQST and NWSA stock pages for the full models.
Not investment advice.